| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3843443 | Actas Urológicas Españolas | 2014 | 8 Pages |
Abstract
Localized renal and non-muscle invasive bladder of high-risk tumors, should be assessed according to comorbidities or oncologic risk factors, to determinate the adequate treatment options. New data from metastatic prostate cancer clinical trials have shown promising results in the control of the disease
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
F. Gómez-Veiga, A. Alcaraz-Asensio, J. Burgos-Revilla, J. Cózar-Olmo,